Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials

Eid, Peter Samuel; Ibrahim, Doaa Alaa; Zayan, Ahmad Helmy; Elrahman, Manal Mahmoud Abd; Shehata, Mostafa; Kandil, Hend; Abouibrahim, Mahmoud; Duy, Luc Minh; Shinkar, Ashraf; Elfaituri, Muhammed Khaled; Minh, Le Huu Nhat; Fahmy, Mostafa Mahmoud; Tam, Dao Ngoc Hien; Vuong, Nguyen Lam; Shah, Jaffer; Dan, Van Buu; Hirayama, Kenji; Huy, Nguyen Tien

doi:10.1007/s10741-020-10003-7

Cited by 20 publications

(15 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, while strengthening the spleen and diuresis, TCM practitioners should also tonify the patient's kidney essence [ 76 ]. For those, who favor kidney yin deficiency, use Liou Wei Di Huang Wan and Er Zhi Wan to tonify kidney yin; for those, who favor yang deficiency, use Gui Bai Di Huang Wan or Jin Kui Kidney Qi Wan to warm up kidney yang [ 77 – 79 ].…”

Section: Treatment Of Pulmonary Oedemamentioning

confidence: 99%

Research Progress on the Mechanism of Right Heart-Related Pulmonary Edema

Wang

Zong

et al. 2022

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Objective. To investigate the mechanisms underlying the development of right heart-associated PE. Background. Right heart-related pulmonary edema (PE) refers to PE resulting from impaired right heart function caused by primary or secondary factors, which is common in critically ill patients. Although the clinical manifestations of different types of right heart-related PE are similar, the pathophysiological changes and treatment methods are significantly different. According to the hemodynamic mechanism, right heart-related PE is primarily classified into two types. One is the increase of right heart flow, including extravascular compression, intravascular compression, cardiac compression, and cardiac decompression. The other type is the abnormal distribution of pulmonary circulation, including obstruction, resistance, pleural decompression, or negative pressure. With the development of hemodynamic monitoring, hemodynamic data not only help us understand the specific pathogenesis of right heart-related PE but also assist us in determining the direction of therapy and enabling individualized treatment. Summary. This article presents a review on right heart-associated PE, with a perspective of hemodynamic analysis, and emphasizes the importance of right heart function in the management of circulation. Understanding the mechanism of right heart-associated PE will not only aid in better monitoring right heart function but also help intensivists make a more accurate identification of various types of PE in the clinic.

show abstract

Section: Treatment Of Pulmonary Oedemamentioning

confidence: 99%

Research Progress on the Mechanism of Right Heart-Related Pulmonary Edema

Wang

Zong

et al. 2022

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

show abstract

“…2). After discharge and at follow-up visits, the diuretic dose should be reconsidered on the basis of clinical and laboratory parameters [55].…”

Section: Diureticsmentioning

confidence: 99%

Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper

et al. 2021

View full text Add to dashboard Cite

The short-term mortality and rehospitalization rates after admission for acute heart failure (AHF) remain high, despite the high level of adherence to contemporary practice guidelines. Observational data from non-randomized studies in AHF strongly support the in-hospital administration of oral evidence-based modifying chronic heart failure (HF) medications (i.e., b-blockers, ACE inhibitors, mineralocorticoid receptor antagonists) to reduce morbidity and mortality. Interestingly, a well-designed prospective randomized multicenter study (PIONEER-HF) showed an improved clinical outcome and stress/injury biomarker profile after in-hospital administration of sacubitril/valsartan (sac/val) as compared to enalapril, in hemodynamically stable patients with AHF. However, sac/val implementation during hospitalization remains suboptimal due to the lack of an integrated individualized plan or well-defined appropriateness criteria for transition to oral therapies, an absence of specific guidelines regarding dose selection and the up-titration process, and uncertainty regarding patient eligibility. In the present expert consensus position paper, clinical practical recommendations are proposed, together with an action plan algorithm, to encourage and facilitate sac/val administration during hospitalization after an AHF episode with the aim of improving efficiencies of care and resource utilization.

show abstract

“…In another meta-analysis [51] of 54 randomized controlled studies in 10,740 patients with heart failure, various diuretic treatment was compared. This study showed that compared to furosemide, torasemide treatment over 1.5-5.6 months of follow-up reduced oedema (relative risk 1.54, 95% CI: 1.01-2.35) and resulted in a greater reduction of blood natriuretic peptide levels.…”

Section: Meta-analyses and Systematic Reviews Comparing Torasemide And Furosemidementioning

confidence: 99%